EPS Diluted (Quarterly) Chart

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2000. Start Trial.
Date Value
September 30, 2026 0.4328
June 30, 2026 0.6913
March 31, 2026 0.4794
December 31, 2025 1.383
September 30, 2025 1.114
June 30, 2025 1.036
March 31, 2025 -0.6644
December 31, 2024 0.9023
September 30, 2024 0.9902
June 30, 2024 0.8794
March 31, 2024 0.5861
December 31, 2023 0.79
September 30, 2023 0.807
June 30, 2023 0.7116
March 31, 2023 0.3891
December 31, 2022 0.5111
September 30, 2022 0.4817
June 30, 2022 0.6248
March 31, 2022 0.3413
December 31, 2021 0.601
September 30, 2021 0.6625
June 30, 2021 0.8851
March 31, 2021 0.6484
December 31, 2020 0.4657
September 30, 2020 0.9173
Date Value
June 30, 2020 0.0117
March 31, 2020 0.9391
December 31, 2019 0.3332
September 30, 2019 0.9249
June 30, 2019 0.8508
March 31, 2019 0.657
December 31, 2018 0.7725
September 30, 2018 3.542
June 30, 2018 0.61
March 31, 2018 0.2504
December 31, 2017 1.694
September 30, 2017 0.4255
June 30, 2017 0.09
March 31, 2017 -0.14
December 31, 2016 0.25
September 30, 2016 0.37
June 30, 2016 -0.03
March 31, 2016 -0.41
December 31, 2015 -0.85
September 30, 2015 0.0008
June 30, 2015 0.35
March 31, 2015 0.31
December 31, 2014 0.54
September 30, 2014 0.54
June 30, 2014 0.48

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
Globus Medical, Inc. 1.038
Abbott Laboratories 0.5294
AngioDynamics, Inc. -0.1689
Alphatec Holdings, Inc. -0.0348
AtriCure, Inc. 0.0816